Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction

AIMS: Udenafil is a cyclic guanosine 3′,5′-monophosphate-specific phosphodiesterase type 5 (PDE5) inhibitor developed for the treatment of erectile dysfunction. The aim was to evaluate the effect of food on the pharmacokinetics of udenafil. METHODS: An open, randomized, three-way crossover study was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kim, Tae-Eun, Kim, Bo-Hyung, Kim, Jung-Ryul, Lim, Kyoung Soo, Hong, Jang Hee, Kim, Kyu-pyo, Kim, Hwa-Sook, Shin, Sang-Goo, Jang, In-Jin, Yu, Kyung-Sang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2009
Konular:
Pharmacokinetics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732939/
https://ncbi.nlm.nih.gov/pubmed/19660002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03404.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller